|
| |
| | | 66808 | | 20.09.2018 | | GlaxoSmithKline AG | | | | | | | | | | | | | 03.99. | | | | 03.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Trelegy Ellipta | Einzeldosiertes Pulver zur Inhalation | Einzeldosiertes Pulver zur Inhalation (Fluticasoni Furoas 100 µg, Umeclidinium 62.5 µg, Vilanterolum 25 µg) | R03AL08 | CI |
|
|
|
